Baclofen for the treatment of alcohol use disorder: the Cagliari Statement, Lancet Psychiatry, vol.5, issue.12, pp.30303-30304, 2018. ,
Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice, Br. J. Pharmacol, vol.162, issue.7, pp.1650-1658, 2011. ,
Alcohol and the human brain: a systematic review of different neuroimaging methods, Alcohol Clin. Exp. Res, vol.35, issue.10, pp.1771-1793, 2011. ,
Cannabinoid CB1 receptors mediate the anxiolytic effects induced by systemic alprazolam and intra-periaqueductal gray 5-HT1A receptor activation, Neurosci Lett, vol.703, pp.5-10, 2019. ,
Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients, Neuropsychopharmacology, vol.36, issue.6, pp.1219-1226, 2011. ,
Fatty acid amide hydrolase, an enzyme with many bioactive substrates. Possible therapeutic implications, Curr Pharm. Des, vol.8, issue.7, pp.533-547, 2002. ,
Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress. Free Radic, Biol. Med, vol.51, issue.5, pp.1054-1061, 2011. ,
Evidence for a potential role for TRPV1 receptors in the dorsolateral periaqueductal gray in the attenuation of the anxiolytic effects of cannabinoids, Prog. Neuro-Psychopharmacology Biol. Psychiatry, vol.33, issue.8, pp.1517-1521, 2009. ,
The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system, Int. J. Neuropsychopharmacol, vol.16, issue.6, pp.1407-1419, 2013. ,
, , 2016.
, Cannabidiol, neuroprotection and neuropsychiatric disorders, Pharmacol Res, vol.112, pp.119-127
Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression, Proc. Natl. Acad. Sci. U S A, vol.103, issue.20, pp.7895-7900, 2006. ,
The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic-ischemic brain damage in mice is mediated by CB2and adenosine receptors, Neurobiol. Dis, vol.37, issue.2, pp.434-440, 2010. ,
Cannabis for paediatric epilepsy: challenges and conundrums, Med. J. Aust, vol.208, issue.3, pp.132-136, 2018. ,
Cannabidiol normalizes caspase 3, synaptophysin, and mitochondrial fission protein DNM1L expression levels in rats with brain iron overload: implications for neuroprotection, Mol. Neurobiol, vol.49, issue.1, pp.222-233, 2014. ,
Transdermal delivery of cannabidiol attenuates binge alcohol-induced neurodenegeneration in a rodent model of an alcohol use disorder, Acc. Chem. Res, vol.45, issue.6, pp.788-802, 2008. ,
Effect of cannabidiol on sepsis-induced motility disturbances in mice: involvement of CB receptors and fatty acid amide hydrolase, Neurogastroenterol. Motil, vol.20, issue.8, pp.919-927, 2008. ,
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes, Br. J. Pharmacol, vol.163, issue.7, pp.1479-1494, 2011. ,
A personal retrospective: elevating anandamide (AEA) by targeting fatty acid amide hydrolase (FAAH) and the fatty acid binding proteins (FABPs), Front. Pharmacol, vol.7, p.370, 2016. ,
Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders, Epilepsia, vol.55, issue.6, pp.791-802, 2014. ,
Serial longitudinal magnetic resonance imaging data indicate non-linear regional gray matter volume recovery in abstinent alcohol-dependent individuals, Addict. Biol, vol.20, issue.5, pp.956-967, 2015. ,
Fatty acid-binding proteins (FABPs) are intracellular carriers for D9-tetrahydrocannabinol (THC) and cannabidiol (CBD), J. Biol. Chem, vol.290, issue.14, pp.8711-8721, 2015. ,
EASL clinical practice guidelines: management of alcohol-related liver disease, J. Hepatol, vol.69, issue.1, pp.154-181, 2018. ,
Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid? Br, J. Clin. Pharmacol, vol.75, issue.2, pp.323-333, 2013. ,
THC inhibits the expression of ethanol-induced locomotor sensitization in mice, Alcohol, vol.65, pp.31-35, 2017. ,
The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: role of neurogenesis and dendritic remodeling, Neuropharmacology, vol.135, pp.22-33, 2018. ,
, Center for Drug Evaluation and Research, Food and Drugs Administration, 2018.
Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical proof of principle, Neuropsychopharmacology, vol.43, issue.10, pp.2036-2045, 2018. ,
Role of the endocannabinoid system in diabetes and diabetic complications, Br. J. Pharmacol, vol.173, issue.7, pp.1116-1127, 2016. ,
Psychopharmacology antianxiety effect of cannabidiol in the elevated plusmaze, Psychopharmacology (Berl), vol.100, pp.558-559, 1990. ,
Comparison of cannabidiol, antioxidant, and diuretics in reversing binge ethanol-induced neurotoxicity, Acc. Chem. Res, vol.45, issue.6, pp.788-802, 2008. ,
Genetic impairment of frontocortical endocannabinoid degradation and high alcohol preference, Neuropsychopharmacology, vol.32, issue.1, pp.117-126, 2007. ,
A systematic review of the antipsychotic properties of cannabidiol in humans, Schizophr. Res, vol.162, issue.1-3, pp.153-161, 2015. ,
The postnatal 5-HT 1A receptor regulates adult anxiety and depression differently via multiple molecules, Prog. Neuro-Psychopharmacology Biol. Psychiatry, vol.78, pp.66-74, 2017. ,
Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on ?-amyloid-induced toxicity in PC12 cells, J. Neurochem, vol.89, issue.1, pp.134-141, 2004. ,
The effects of D 9 -tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis, Br. J. Pharmacol, vol.160, issue.3, pp.712-723, 2010. ,
Face validity of a pre-clinical model of operant binge drinking: just a question of speed, Addict. Biol, 2018. ,
Animal models of binge drinking: behavior and clinical relevance. Neurosci. Alcohol 57-66, 2019. ,
Determination of genotype combinations that can predict the outcome of the treatment of alcohol dependence using the 5-HT 3 antagonist ondansetron, Am. J. Psychiatry, vol.170, issue.9, pp.1020-1031, 2013. ,
Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and D 9-tetrahydrocannabinol in BV-2 microglial cells, Br. J. Pharmacol, vol.165, issue.8, pp.2512-2528, 2012. ,
Antifibrogenic role of the cannabinoid receptor CB2 in the liver, Gastroenterology, vol.128, issue.3, pp.742-755, 2005. ,
The therapeutic potential of the phytocannabinoid cannabidiol for Alzheimer's disease, Behav. Pharmacol, vol.28, issue.2, pp.142-160, 2017. ,
Delta-9-tetrahydrocannabinol/cannabidiol oromucosal spray (Sativex ® ): a review in multiple sclerosis-related spasticity, Drugs, vol.77, issue.5, pp.563-574, 2017. ,
Intra-cerebral cannabidiol infusion-induced neuroprotection is partly associated with the TNF-?/TNFR1/NF-?B pathway in transient focal cerebral ischaemia, Brain Inj, vol.31, pp.1932-1943, 2017. ,
Modulation of astrocyte activity by cannabidiol, a nonpsychoactive cannabinoid, Int. J. Mol Sci, vol.18, issue.8, 2017. ,
Cannabidiol is a negative allosteric modulator of the cannabinoid CB 1 receptor, Br. J. Pharmacol, vol.172, issue.20, pp.4790-805, 2015. ,
Cannabidiol limits T cell-mediated chronic autoimmune myocarditis: implications to autoimmune disorders and organ transplantation, Mol. Med, vol.22, issue.1, p.1, 2016. ,
Cannabidiol regulation of emotion and emotional memory processing: relevance for treating anxiety-related and substance abuse disorders, Br. J. Pharmacol, vol.174, pp.3242-3256, 2017. ,
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia, Transl. Psychiatry, vol.2, issue.3, p.94, 2012. ,
Cannabidiol causes activated hepatic stellate cell death through a mechanism of endoplasmic reticulum stress-induced apoptosis, Cell Death Dis, vol.2, issue.6, pp.1-11, 2011. ,
Cannabidiol presents an inverted U-shaped dose-response curve in the simulated public speaking test, Braz. J. Psychiatry, vol.41, issue.1, pp.9-14, 2016. ,
CB2 receptors as new therapeutic targets for liver diseases, Br. J. Pharmacol, vol.153, issue.2, pp.286-289, 2008. ,
Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating Kupffer cell polarization in mice, Hepatology, vol.54, issue.4, pp.1217-1226, 2011. ,
Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation, J. Hepatol, vol.51, issue.3, pp.528-534, 2009. ,
Immunity and inflammatory signaling in alcoholic liver disease, Hepatol Int, vol.8, issue.S2, pp.439-446, 2014. ,
Nalmefene for the management of alcohol dependence: review on its pharmacology, mechanism of action and meta-analysis on its clinical efficacy, Eur. Neuropsychopharmacol, vol.26, issue.12, pp.1941-1949, 2016. ,
Binding and signaling studies disclose a potential allosteric site for cannabidiol in cannabinoid CB2 receptors, Front. Pharmacol, vol.8, p.744, 2017. ,
5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid, J. Neurochem, vol.104, issue.4, pp.1091-1100, 2008. ,
Cannabidiol as potential anticancer drug, Br. J. Clin. Pharmacol, vol.75, issue.2, pp.303-312, 2013. ,
Cannabidiol (CBD) as an adjunctive therapy in schizophrenia: a multicenter randomized controlled trial, Am. J. Psychiatry, vol.175, issue.3, pp.225-231, 2018. ,
Postdependent state in rats as a model for medication development in alcoholism, Addict. Biol, vol.20, issue.1, pp.1-21, 2015. ,
Acute and chronic administration of a low-dose combination of topiramate and ondansetron reduces ethanol's reinforcing effects in male alcohol preferring (P) rats, Exp. Clin. Psychopharmacol, vol.22, issue.1, pp.35-42, 2014. ,
, Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia, 2017.
, Neuro-Psychopharmacology Biol. Psychiatry, vol.75, pp.94-105
A novel crosstalk within the endocannabinoid system controls GABA transmission in the striatum, Sci. Rep, vol.7, issue.1, p.7363, 2017. ,
Neuroimmune interface in the comorbidity between alcohol use disorder and major depression, Front. Immunol. Dec, vol.7, p.655, 2016. ,
Practice Guideline Committee of the American Association for the Study of Liver Diseases, Practice Parameters Committee of the American College of Gastroenterology. Alcoholic liver disease, Hepatology, vol.51, issue.1, pp.307-328, 2010. ,
Cannabinoid activation of peroxisome proliferator-activated receptors: potential for modulation of inflammatory disease, Immunobiology, vol.215, issue.8, pp.611-616, 2010. ,
Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta-analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate, Addiction, vol.113, issue.2, pp.220-237, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01696955
Mechanisms of cannabidiol neuroprotection in hypoxic-ischemic newborn pigs: role of 5HT(1A) and CB2 receptors, Neuropharmacology, vol.71, pp.282-291, 2013. ,
The diverse CB 1 and CB 2 receptor pharmacology of three plant cannabinoids: D 9-tetrahydrocannabinol, cannabidiol and D 9-tetrahydrocannabivarin, Br. J. Pharmacol, vol.153, issue.2, pp.199-215, 2008. ,
Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy, J. Am. Coll. Cardiol, vol.56, issue.25, pp.2115-2125, 2010. ,
Global burden of alcoholic liver diseases, J. Hepatol, vol.59, issue.1, pp.160-168, 2013. ,
Pharmacological activation of CB2 receptors counteracts the deleterious effect of ethanol on cell proliferation in the main neurogenic zones of the adult rat brain, Front. Cell Neurosci, vol.9, p.379, 2015. ,
Cannabidiol, a non-psychotropic component of Cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT(1A) somatodendritic autoreceptors in the dorsal raphe nucleus, Br. J. Pharmacol, vol.165, issue.8, pp.2620-2634, 2012. ,
Pharmacotherapy for alcohol dependence: the 2015 Recommendations of the French Alcohol Society, Issued in Partnership with the European Federation of Addiction Societies, CNS Neurosci. Ther, vol.22, issue.1, pp.25-37, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01276028
Inhibition of recombinant human T-type calcium channels by delta9-tetrahydrocannabinol and cannabidiol, J. Biol. Chem, vol.283, issue.23, pp.16124-16134, 2008. ,
Agonistic properties of cannabidiol at 5-HT1a receptors, Neurochem. Res, vol.30, issue.8, pp.1037-1043, 2005. ,
Cannabidiol targets mitochondria to regulate intracellular Ca2+ levels, J. Neurosci, vol.29, issue.7, pp.2053-2063, 2009. ,
The orphan receptor GPR55 is a novel cannabinoid receptor, Br. J. Pharmacol, vol.152, issue.7, pp.1092-1101, 2009. ,
The neuroprotection of cannabidiol against MPP+-induced toxicity in PC12 cells involves trkA receptors, upregulation of axonal and synaptic proteins, neuritogenesis, and might be relevant to Parkinson's disease, Toxicol. Vitr, vol.30, issue.1, pp.231-240, 2015. ,
Alcohol dependence and anxiety disorders: what is the relationship?, Am. J. Psychiatry, vol.151, issue.12, pp.1723-1734, 1994. ,
Recovery of neurocognitive functions following sustained abstinence after substance dependence and implications for treatment, Clin. Psychol. Rev, vol.34, issue.7, pp.531-550, 2014. ,
Two non-psychoactive cannabinoids reduce intracellular lipid levels and inhibit hepatosteatosis, J. Hepatol, vol.62, issue.6, pp.1382-1390, 2015. ,
Pharmacotherapy of alcoholism-an update on approved and off-label medications, Expert Opin Pharmacother, vol.18, issue.12, pp.1187-1199, 2017. ,
Is the cardiovascular system a therapeutic target for cannabidiol? Br, J. Clin. Pharmacol, vol.75, issue.2, pp.313-322, 2013. ,
Widespread and sustained cognitive deficits in alcoholism: a meta-analysis, Addict. Biol, vol.18, issue.2, pp.203-213, 2013. ,
Cannabidiol disrupts the consolidation of specific and generalized fear memories via dorsal hippocampus CB 1 and CB 2 receptors, Neuropharmacology, vol.125, pp.220-230, 2017. ,
Beneficial paracrine effects of cannabinoid receptor 2 on liver injury and regeneration, Hepatology, vol.52, issue.3, pp.1046-1059, 2010. ,
URL : https://hal.archives-ouvertes.fr/inserm-00519450
Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors, Br. J. Pharmacol, vol.176, issue.10, pp.1455-1469, 2019. ,
Serotonin receptors and suicide, major depression, alcohol use disorder and reported early life adversity, Transl. Psychiatry, vol.8, issue.1, p.279, 2018. ,
Cannabidiol reduces ethanol consumption, motivation and relapse in mice, Addict. Biol, vol.23, issue.1, pp.154-164, 2018. ,
Effects of cannabidiol plus naltrexone on motivation and ethanol consumption, Br. J. Pharmacol, vol.175, issue.16, pp.3369-3378, 2018. ,
Cannabidiol attenuates alcohol-induced liver steatosis, metabolic dysregulation, inflammation and neutrophil-mediated injury, Sci. Rep, vol.7, issue.1, pp.1-12, 2017. ,
Structural insight into the serotonin (5-HT) receptor family by molecular docking, molecular dynamics simulation and systems pharmacology analysis, Acta Pharmacol. Sin, vol.0, pp.1-19, 2019. ,
Distribution and characterization of anandamide amidohydrolase in mouse brain and liver, Life Sci, vol.62, issue.14, pp.1223-1229, 1998. ,
Alcohol and opioid use, co-use, and chronic pain in the context of the opioid epidemic: a critical review, Alcohol Clin. Exp. Res, vol.42, issue.3, pp.478-488, 2018. ,
, Global status report on alcohol and health, World Health Organization, 2018.
Cannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including inhibition of oxidative stress and increase in autophagy. Free Radic, Biol. Med, vol.68, pp.260-267, 2014. ,
Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT 1A receptors, Br. J. Pharmacol, vol.159, issue.1, pp.122-128, 2010. ,
Cannabidiol in humans-the quest for therapeutic targets, Pharmaceuticals (Basel), vol.5, issue.5, pp.529-552, 2012. ,
Regional brain volume changes in alcohol-dependent individuals during short-term and long-term abstinence, Alcohol Clin. Exp. Res, vol.42, issue.6, pp.1062-1072, 2018. ,